Company Daebongls.Co.,Ltd.

A078140

KR7078140001

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06/03/2026			5-day change	1st Jan Change
11,000.00 ^KRW	+3.19%		-2.22%	-5.58%

14/11	Daebongls.Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
06/11	Daebongls.Co.,Ltd. announces Annual dividend, payable on April 24, 2026	CI

Business description: Daebongls.Co.,Ltd.

Daebongls. Co., Ltd. is a Korea-based company engaged in the manufacture of raw materials for pharmaceuticals and cosmetics. The Company operates its business through two main divisions: cosmetic division, which provides aloe vera gels, beta carotens, calamines, diaformers, emulgades and others for conditioners, emulsifiers, emollients, polymers, thickeners and others; pharmaceutical division, which provides almagates, bentonites, calcitriols, erdosteines, fish oil and others for antibiotics, cough products, expectorants and others. In addition, it is involved in the provision of food chemical additives, fish feedstuff and others. The Company distributes its products within domestic market and to overseas markets, including Japan, America and other Southeast Asian countries.

Number of employees: 131

Sales by Activity: Daebongls.Co.,Ltd.

Fiscal Period: December	2020 (KRW)	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)
Manufacturing Sector	6.12TCr	6.51TCr	7.52TCr	7.25TCr	7.58TCr
Research Department	1.47TCr	1.75TCr	1.79TCr	1.48TCr	1.78TCr
Wholesale Sector	36Cr	34Cr	33Cr	29Cr	30Cr
Unallocated Adjustment	-	-	-	-1.86Cr	-99.21L

See all business segments

Geographical breakdown of sales: Daebongls.Co.,Ltd.

Fiscal Period: December	2020 (KRW)	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)
South Korea	7.47TCr	8.12TCr	9.22TCr	8.6TCr	9.24TCr
Export	158.43Cr	175.46Cr	133.93Cr	158.59Cr	158.2Cr

See all geographic segments

Executive Committee: Daebongls.Co.,Ltd.

Manager	Title	Age	Since
Jong-Ho Park CEO	Chief Executive Officer	80	27/03/2013
Jin-Oh Park CEO	Chief Executive Officer	54	10/05/2011
Jae-Yeon Im PRN	Corporate Officer/Principal	58	30/03/2021
Jong-Woo Kim AUD	Comptroller/Controller/Auditor	68	29/03/2023
Chang-Woo Son DFI	Director of Finance/CFO	58	10/05/2011

See DAEBONGLS.CO.,LTD. governance

Composition of the Board of Directors: Daebongls.Co.,Ltd.

Director	Title	Age	Since
Jin-Oh Park BRD	Director/Board Member	54	10/05/2011
Jong-Ho Park BRD	Director/Board Member	80	27/03/2013
Jae-Yeon Im BRD	Director/Board Member	58	30/03/2021

Composition of the Board of Directors

Shareholders: Daebongls.Co.,Ltd.

Name	Equities	%	Valuation
Jin-Oh Park 22.6 %	25,05,600	22.6 %	21 M ₩
Jong-Ho Park 19.55 %	21,67,900	19.55 %	18 M ₩
Ji-won Lee 2.724 %	3,02,000	2.724 %	3 M ₩
Se-in Park 2.616 %	2,90,000	2.616 %	2 M ₩
Se-hyeon Park 1.984 %	2,20,000	1.984 %	2 M ₩

List of DAEBONGLS.CO.,LTD. shareholders

Holdings: Daebongls.Co.,Ltd.

Name	Equities	%	Valuation
P&K SKIN RESEARCH CENTER CO., LTD. 55.91%	1,67,79,844	55.91%	28 M $
DAEBONGLS.CO.,LTD. 1.25%	1,38,410	1.25%	1 M $

Company details: Daebongls.Co.,Ltd.

DaebongLS Co., Ltd.

123 Neungheodae-ro 649 beon-gil

21697, Inchon

http://www.daebongls.co.kr

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
DAEBONGLS.CO.,LTD.	+3.19%	-2.22%	-18.88%	+38.02%	7.95Cr
ELI LILLY AND COMPANY	+0.72%	-3.10%	+6.52%	+211.00%	88TCr
JOHNSON & JOHNSON	+0.32%	-1.26%	+45.59%	+56.08%	58TCr
ABBVIE INC.	-0.96%	+2.41%	+8.78%	+47.45%	41TCr
ROCHE HOLDING AG	-2.93%	-6.16%	+12.53%	+24.59%	36TCr
ASTRAZENECA PLC	-1.85%	-4.04%	+20.21%	+34.46%	30TCr
NOVARTIS AG	-1.25%	-3.78%	+23.26%	+55.34%	30TCr
MERCK & CO., INC.	-0.24%	-2.94%	+24.25%	+8.34%	29TCr
AMGEN INC.	+0.53%	-2.58%	+16.73%	+57.37%	20TCr
GILEAD SCIENCES, INC.	-0.83%	+0.11%	+24.68%	+77.54%	18TCr
Average	-0.27%	-1.48%	+16.37%	+61.02%	35TCr
Weighted average by Cap.	-0.49%	-1.65%	+19.46%	+86.04%